Lin YS - Search Results

1

Identifying safer anti-wear triaryl phosphate additives for jet engine lubricants.

Baker PE, Cole TB, Cartwright M, Suzuki SM, Thummel KE, Lin YS, Co AL, Rettie AE, Kim JH, Furlong CE. Baker PE, et al. Among authors: lin ys. Chem Biol Interact. 2013 Mar 25;203(1):257-64. doi: 10.1016/j.cbi.2012.10.005. Epub 2012 Oct 22. Chem Biol Interact. 2013. PMID: 23085349 Free PMC article.

2

Transcriptional control of intestinal cytochrome P-4503A by 1alpha,25-dihydroxy vitamin D3.

Thummel KE, Brimer C, Yasuda K, Thottassery J, Senn T, Lin Y, Ishizuka H, Kharasch E, Schuetz J, Schuetz E. Thummel KE, et al. Mol Pharmacol. 2001 Dec;60(6):1399-406. doi: 10.1124/mol.60.6.1399. Mol Pharmacol. 2001. PMID: 11723248

3

In-vivo phenotyping for CYP3A by a single-point determination of midazolam plasma concentration.

Lin YS, Lockwood GF, Graham MA, Brian WR, Loi CM, Dobrinska MR, Shen DD, Watkins PB, Wilkinson GR, Kharasch ED, Thummel KE. Lin YS, et al. Pharmacogenetics. 2001 Dec;11(9):781-91. doi: 10.1097/00008571-200112000-00006. Pharmacogenetics. 2001. PMID: 11740342

4

Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism.

Lin YS, Dowling AL, Quigley SD, Farin FM, Zhang J, Lamba J, Schuetz EG, Thummel KE. Lin YS, et al. Mol Pharmacol. 2002 Jul;62(1):162-72. doi: 10.1124/mol.62.1.162. Mol Pharmacol. 2002. PMID: 12065767

5

Genetic contribution to variable human CYP3A-mediated metabolism.

Lamba JK, Lin YS, Schuetz EG, Thummel KE. Lamba JK, et al. Among authors: lin ys. Adv Drug Deliv Rev. 2002 Nov 18;54(10):1271-94. doi: 10.1016/s0169-409x(02)00066-2. Adv Drug Deliv Rev. 2002. PMID: 12406645 Review.

6

CYP2C9 exon 4 mutations and warfarin dose phenotype in Asians.

Rettie AE, Tai G, Veenstra DL, Farin FM, Srinouanprachan S, Lin YS, Thummel KE, Hines RN. Rettie AE, et al. Among authors: lin ys. Blood. 2003 Apr 1;101(7):2896-7. doi: 10.1182/blood-2002-11-3452. Blood. 2003. PMID: 12642346 Free article. No abstract available.

7

Transiently altered acetaminophen metabolism after liver transplantation.

Park JM, Lin YS, Calamia JC, Thummel KE, Slattery JT, Kalhorn TF, Carithers RL Jr, Levy AE, Marsh CL, Hebert MF. Park JM, et al. Among authors: lin ys. Clin Pharmacol Ther. 2003 Jun;73(6):545-53. doi: 10.1016/S0009-9236(03)00062-6. Clin Pharmacol Ther. 2003. PMID: 12811364 Clinical Trial.

8

Association between ABCB1 (multidrug resistance transporter) genotype and post-liver transplantation renal dysfunction in patients receiving calcineurin inhibitors.

Hebert MF, Dowling AL, Gierwatowski C, Lin YS, Edwards KL, Davis CL, Marsh CL, Schuetz EG, Thummel KE. Hebert MF, et al. Among authors: lin ys. Pharmacogenetics. 2003 Nov;13(11):661-74. doi: 10.1097/00008571-200311000-00002. Pharmacogenetics. 2003. PMID: 14583679

9

Differences in the inhibition of cytochromes P450 3A4 and 3A5 by metabolite-inhibitor complex-forming drugs.

McConn DJ 2nd, Lin YS, Allen K, Kunze KL, Thummel KE. McConn DJ 2nd, et al. Among authors: lin ys. Drug Metab Dispos. 2004 Oct;32(10):1083-91. doi: 10.1124/dmd.32.10.. Drug Metab Dispos. 2004. PMID: 15377640

10

Evidence of significant contribution from CYP3A5 to hepatic drug metabolism.

Huang W, Lin YS, McConn DJ 2nd, Calamia JC, Totah RA, Isoherranen N, Glodowski M, Thummel KE. Huang W, et al. Among authors: lin ys. Drug Metab Dispos. 2004 Dec;32(12):1434-45. doi: 10.1124/dmd.104.001313. Epub 2004 Sep 21. Drug Metab Dispos. 2004. PMID: 15383492

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,231 results

Search Page